Go Pro

Biodexa Pharmaceuticals (BDRX) News Today

Biodexa Pharmaceuticals logo
$0.85 +0.05 (+6.21%)
As of 09/4/2026 04:00 PM Eastern

Biodexa Pharmaceuticals Latest News

Result of General Meeting
Result of Annual General Meeting
Biodexa Pharmaceuticals plc Sponsored ADR
Biodexa issues letter to Shareholders
Preliminary Results for the Year Ended 31 December 2025
ADR Ratio Change
Biodexa Announces Pricing of $10 Million Public Offering
Interim results for the six months ended June 30, 2025
ADR Ratio Change Effective
ADR Ratio Change
Results of Annual General Meeting

Biodexa Pharmaceuticals Media Mentions By Week

Biodexa Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BDRX
News Sentiment

0.00

0.77

Average
Healthcare
News Sentiment

Biodexa Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BDRX Articles
This Week

0

2

BDRX Articles
Average Week

Biodexa Pharmaceuticals Trends on MarketBeat

This week vs. last week
Page Views
1,341
-4%
Get Biodexa Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDRX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Biodexa Pharmaceuticals dated 8/19/2026.
From Our Partners